“a nonsignificant trend”

There was a nonsignificant trend for an effect of diet, with weights tending to be higher on the low-quality diet ( B = −0.313, 95% CI −0.672 to 0.047, z = −1.705, P = 0.088).

Fibula length showed a nonsignificant trend toward a more proximal perforator position ( p = 0.088), while fibular artery stenosis and anomalies of the remaining lower‐leg arteries were not associated with perforator location.

When analyzed as a continuous variable, gestational age showed a nonsignificant trend toward variation (p = 0.088), but this association disappeared when gestational age was categorized into week-based groups (p = 0.223), indicating no meaningful differences in gestational age distribution by ACS exposure.

Of note, no significant benefit from adjuvant chemotherapy was observed in CMS1 or CMS4, although a nonsignificant trend was observed in CMS4 stage III disease (log-rank test P = .089; Data Supplement).

There was a nonsignificant trend toward higher admission and peak troponins (0.7 vs. 0.2 ng/ml p = 0.089 and 1.0 vs. 0.2 ng/mL p = 0.13, respectively) in the infliximab group.

Functional improvement was observed across all treatment groups, with a nonsignificant trend favoring surgical interventions ( P = 0.089).

There was a nonsignificant trend toward greater systolic blood pressure in women than in men (P = 0.089).

A nonsignificant trend for a lower differential CS+/CS− SCR in the DCS group, compared to placebo, ( b = −0.25, CI = 0.04 to −0.55, p = 0.089) was observed at retention testing, one week later.

However, survival time differed significantly based on FEV1 z -score severity categories (log-rank test, χ 2 = 8.384, p = 0.039), and FVC severity (log-rank test, χ 2 = 11.972, p = 0.007; Table 2 and Figure 1 ). The univariate Cox regression analyses revealed that lower FEV1 z -score (HR = 0.407, 95% confidence interval [CI]: 0.229–0.721, p = 0.002), FVC z -score (HR = 0.452, 95% CI: 0.248–0.823, p = 0.009), and abdominal circumference (HR = 1.065, 95% CI: 1.02–1.112, p = 0.005) were significantly associated with an increased mortality risk in individuals with SMI, while age showed a nonsignificant trend toward an association with mortality (HR = 1.105, 95% CI: 0.982–1.233, p = 0.089).

Multivariate Cox regression analysis revealed that, for OS, FIGO stage (HR, 6.024; 95% CI, 1.961–10.258; P<0.001) and lymph node metastasis (HR, 1.703; 95% CI, 1.080–2.673; P=0.039) were significant independent prognostic factors, whilst treatment modality revealed a nonsignificant trend (HR, 1.517; 95% CI, 0.784–2.361; P=0.089) ( Table VIII ).

Furthermore, strong CXCR 4 expression revealed a significant association with low hemoglobin values ( P = .039) and a nonsignificant trend towards increased thrombocytes ( P = .089/ P = .18, resp.).

In stages III and IV cancers, low levels of Bif-1 expression were associated with a nonsignificant trend toward a poorer clinical outcome ( P = 0.089; Figure 2(b) , and P = 0.158; Figure 2(c) , resp.).

There was a nonsignificant trend of large volume paracentesis (Figure 3B , sHR 2.40, 95% CI 0.87–6.60, p = 0.089), higher CLIF‐OF score (sHR 1.17 per 1 unit increase, 95% CI 0.98–1.39, p = 0.086), and nosocomial SBP (sHR 1.93, 95% CI 0.90–4.11, p = 0.089) being associated with the outcome. 4 Discussion There was no significant association between therapeutic paracentesis timing or volume of ascites removed on the development of AKI or circulatory dysfunction in patients with cirrhosis and SBP.

Programs with a CE track had a nonsignificant trend toward higher odds (OR 2.6; 95 CI 0.86–7.88; p = 0.089) of offering a medical education elective to residents.

A nonsignificant trend for the three-way interaction was obtained, F (2, 90) = 2.49, MSE = 136.51, p = .089, η p 2 = .05, however the interaction between training condition and testing status was nonsignificant when examined for negative and positive words separately, p > .10 in both cases.

S1 ), but a nonsignificant trend toward increased clonality was observed when comparing samples from right-sided with left-sided primary tumors ( P = 0.09, Supplementary Fig.

For the genetic score, there was a nonsignificant trend towards better quality in HuGE reviews (16% difference; P = 0.090).

Notably, the N400 and the “certainty scores” showed a significant positive correlation at parietal-left electrodes ( r = 0.22, P = 0.03 Bonferroni corrected) and a nonsignificant trend at the parietal-right electrodes ( r = 0.18, P = 0.09 Bonferroni corrected) ( Fig. 3 c ).

A significant association was observed between BMI and AFO on spirometry (coefficient = −0.137; P = 0.02), percentage predicted FEV 1 (coefficient = 0.14; P = 0.02), FVC (coefficient = 0.13; P = 0.03), and peak expiratory flow (coefficient = 0.14; P = 0.02), with a nonsignificant trend noted between BMI and FEV 25%–75% (coefficient = 0.1; P = 0.09).

Side of involvement showed a nonsignificant trend toward a higher proportion of left knees in the damage group (59.02% vs 44.94%; χ2 = 2.868, P = .090).

When correlating the weight of the tumor with the relative αv expression, we found a nonsignificant trend for lower αv expression in larger tumors ( r = 0.34, p = 0.09).

2 , the main effect of drink approached significance ( F [1,21] = 2.98, p = 0.09), such that there was a nonsignificant trend for better global cognitive function following the FR drink relative to the control; however, the planned contrasts were not performed in light of the nonsignificant ANOVA model.

The DHEA/CORT ratio was positively correlated with DCX-immunoreactive cells in the dentate gyrus ( p = 0.04); further, a nonsignificant trend was observed suggesting an inverse correlation between DHEA/CORT ratios and fos-immunoreactive cells in the habenula ( p = 0.09).

In the study that found the open approach better, the result was confounded by nerve sparing, so robotic prostatectomies showed a nonsignificant trend toward lower PSM for a non-nerve-sparing approach ( P = .09) [ 10 ].

The rationale for this is based on animal models suggesting that statins can attenuate organ dysfunction by reducing vascular leak and inflammation.[ 84 ] A prospective cohort study in Ireland showed a nonsignificant trend towards lower odds of death in ARDS patients receiving a statin during their ICU admission (OR 0.27, 95% CI 0.06, 1.21; p = 0.09).[ 83 ] However, a recently published retrospective cohort study from the Mayo Clinic (Rochester, MN, USA) showed no difference in mortality or organ dysfunction in ARDS